13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0000902664-25-003554
Total Value
$58.6M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 5,664,548 | $36.8M | 62.80% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $6.6M | 11.28% |
| 3 | TG THERAPEUTICS INC | TGTX | 161,600 | $5.8M | 9.92% |
| 4 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $3.0M | 5.13% |
| 5 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $2.1M | 3.55% |
| 6 | CURIS INC | CRIS | 521,059 | $1.2M | 2.06% |
| 7 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $1.1M | 1.83% |
| 8 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.1M | 1.82% |
| 9 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $944,916 | 1.61% |